Effect of Cytisine vs Varenicline on Smoking Cessation

Ryan J. Courtney; Hayden McRobbie; Piotr Tutka; Natasha Weaver; Dennis Petrie; Colin Mendelsohn; Anthony Shakeshaft; Saki Rubaiya Talukder; Christel Macdonald; Dennis Thomas; Benjamin C. H. Kwan; Natalie Walker; Coral Gartner; Richard P. Mattick; Christine Paul; Stuart G. Ferguson; Nicholas Zwar; Robyn Richmond; Christopher M. Doran; Veronica Boland; Wayne Hall; Robert West; Michael Farrell

doi:10.1001/jama.2021.7621

Key Points

To compare the efficacy and safety of cytisine versus varenicline as pharmacotherapies for smoking cessation.
Randomized clinical trial registered under trial identifier ACTRN12616001654448.
Evaluated smoking abstinence and treatment outcomes in adult smokers receiving cytisine or varenicline.
Numerical abstinence rates, effect sizes, and confidence intervals are not reported in the provided registry entry text.
Trial endpoints measure comparative verified tobacco abstinence rates and adverse event profiles between arms.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Randomized trial reports smoking cessation outcomes for cytisine versus varenicline in adult smokers, highlighting affordable pharmacotherapy alternatives.

Abstract

anzctr.org.au Identifier: ACTRN12616001654448.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Courtney et al. (2021) studied this question.

synapsesocial.com/papers/69d7f9e23eff0c9dfaae2edc https://doi.org/10.1001/jama.2021.7621

View Full Paper

Ask AI

Bookmark

Share

Effect of Cytisine vs Varenicline on Smoking Cessation

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Effect of Cytisine vs Varenicline on Smoking Cessation

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading